Roxanne Lagano - Feb 14, 2023 Form 4 Insider Report for Zoetis Inc. (ZTS)

Role
Executive Vice President
Signature
/s/ Brenda Santuccio, as Attorney-in-Fact
Stock symbol
ZTS
Transactions as of
Feb 14, 2023
Transactions value $
-$1,237,907
Form type
4
Date filed
2/16/2023, 03:18 PM
Previous filing
Feb 14, 2023
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZTS Common Stock Options Exercise $512K +6.98K +26.5% $73.24 33.3K Feb 14, 2023 Direct F1
transaction ZTS Common Stock Options Exercise $527K +6.03K +18.07% $87.51 39.4K Feb 14, 2023 Direct F1
transaction ZTS Common Stock Sale -$2.28M -13K -33.05% $175.00 26.4K Feb 14, 2023 Direct F2
holding ZTS Common Stock 796 Feb 14, 2023 401(k) F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZTS Stock Option Options Exercise $0 -6.98K -18.59% $0.00 30.6K Feb 14, 2023 Common Stock 6.98K Direct F4, F5, F6, F7, F8
transaction ZTS Stock Option Options Exercise $0 -6.03K -19.7% $0.00 24.6K Feb 14, 2023 Common Stock 6.03K Direct F4, F6, F7, F9, F10
holding ZTS Stock Option 6.54K Feb 14, 2023 Common Stock 6.54K $162.07 Direct F7, F11, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 25, 2022.
F2 The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.
F3 Represents the common stock equivalents held in the Zoetis Inc. Savings Plan, a 401(k) plan, as of December 31, 2022.
F4 Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
F5 6,984 options granted February 13, 2018 at an exercise price of $73.24 per option.
F6 Each option vests on the third anniversary of the date of grant.
F7 Each option expires on the tenth anniversary of the date of grant.
F8 2,328 options granted February 13, 2018 at an exercise price of $73.24 per option; 8,036 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option.
F9 6,026 options granted on February 12, 2019 at an exercise price of $87.51 per option.
F10 2,328 options granted February 13, 2018 at an exercise price of $73.24 per option; 2,010 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option.
F11 Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
F12 One-third of each option will vest on the first, second and third anniversaries of the date of grant.